When You Eat Lion’s Mane Every Day, Here’s What Happens to Your Body!

Forgetting names moments after meeting someone. Walking into rooms with no memory of why. Searching mid-sentence for words that feel just out of reach. Most people accept these experiences as unavoidable features of aging. What the science of neuroplasticity has established, however, is that the adult brain retains the capacity for growth, adaptation, and the formation of new neural connections far longer than was previously understood — and that specific bioactive compounds can meaningfully influence this process.

Lion’s Mane mushroom (Hericium erinaceus) is one of the most studied mushrooms in modern neuroscience, not because of folklore or supplement marketing, but because it contains two groups of bioactive compounds — hericenones and erinacines — that are not found in any other food source and have been shown in peer-reviewed research to cross the blood-brain barrier and influence the production of proteins critical to neural health. This article examines what the human clinical evidence actually shows, what the mechanistic laboratory research has established, and where the genuine gaps in the current evidence base remain.

What This Article Covers

• What Lion’s Mane is and what makes its bioactive compounds unique
• The NGF and BDNF mechanisms — how hericenones and erinacines work
• The landmark human clinical trial on mild cognitive impairment
• The University of Queensland research on new neuroprotective compounds
• The early Alzheimer’s disease 49-week pilot study
• Acute cognitive effects in healthy adults
• Gut-brain axis and mood effects
• Practical protocol, quality considerations, and safety information

What Is Lion’s Mane and What Makes It Biologically Unique

Hericium erinaceus grows on hardwood trees in North America, Asia, and Europe, distinguished from conventional mushrooms by its cascading white spines resembling a lion’s mane rather than the typical cap-and-stem structure. It has been used in traditional Chinese medicine for gastrointestinal and neurological conditions for over two thousand years. Japanese Buddhist monks called it Yamabushitake and reportedly consumed it before meditation to support mental clarity and focus.

Modern phytochemical analysis identified two groups of unique bioactive compounds that exist only in Hericium erinaceus:

• Hericenones (C–H) — isolated from the fruiting body; these compounds are small enough to cross the blood-brain barrier and stimulate Nerve Growth Factor (NGF) synthesis in brain tissue
• Erinacines (A–I) — found primarily in the mycelium; diterpenoids that directly stimulate NGF synthesis and promote neuronal outgrowth, with erinacine A being the most extensively studied

Neither compound class is found in any other food or mushroom. Their capacity to cross the blood-brain barrier and directly influence neurotrophin production is what makes Lion’s Mane neurologically significant beyond the beta-glucan polysaccharides it shares with other medicinal mushrooms.

The NGF and BDNF Mechanisms: How Lion’s Mane Works at the Cellular Level

Nerve Growth Factor (NGF)

NGF is a protein essential for the growth, maintenance, and survival of neurons — particularly cholinergic neurons in the basal forebrain that are critical for memory and learning. NGF stimulates the elongation of neurites — the projecting branches that extend from neuron cell bodies to form synaptic connections with other neurons. The more neurite branches, the richer the neural network and the more efficiently information is processed and stored.

Critically, the brain’s own capacity to produce NGF declines with age — and this decline is directly associated with the progression of cognitive impairment. Hericenones and erinacines promote NGF synthesis without directly acting as NGF itself, which means they stimulate the brain’s endogenous production rather than externally supplying the protein. Research published in the Journal of Agricultural and Food Chemistry by Lai et al. (2013) confirmed that Lion’s Mane extract demonstrated neurotrophic properties including stimulation of neurite outgrowth by over 60% in laboratory neuronal cell models — one of the most significant neurotrophic effects documented from a food-derived compound.

Brain-Derived Neurotrophic Factor (BDNF)

BDNF is a second neurotrophin — often described as the brain’s primary growth factor — that plays a central role in memory formation, learning, and long-term potentiation (the molecular process underlying memory consolidation). BDNF also promotes neurogenesis: the birth of new neurons in the hippocampus, the brain’s primary memory centre. Declining BDNF is directly associated with depression, cognitive deterioration, and Alzheimer’s pathology.

Research from the University of Queensland, published in the Journal of Neurochemistry by Martínez-Mármol et al. (2023), identified new active compounds in Lion’s Mane — including hericene A — that activate BDNF signaling pathways and promote hippocampal neuron growth in laboratory models. The University of Queensland research team characterized these as a previously unidentified mechanism through which Lion’s Mane supports brain plasticity, independent of the already-established NGF pathway.

The Landmark Human Clinical Trial: Mild Cognitive Impairment

The foundational human clinical evidence for Lion’s Mane comes from a double-blind, placebo-controlled trial by Mori et al. (2009) published in Phytotherapy Research. The study enrolled 30 Japanese men and women aged 50–80 who had been diagnosed with mild cognitive impairment — the stage between normal age-related cognitive change and clinical dementia. Participants were randomized to two groups of 15.

The Lion’s Mane group consumed four 250 mg tablets containing 96% Hericium erinaceus dry powder three times daily (approximately 3 grams total daily dose) for 16 weeks. Cognitive function was assessed at weeks 8, 12, and 16 using the Revised Hasegawa Dementia Scale (HDS-R), a validated cognitive screening instrument.

Results: the Lion’s Mane group showed statistically significant improvements in cognitive function scores at weeks 8, 12, and 16 compared to placebo. The placebo group’s scores showed no improvement and slight decline across the same measurement periods. Four weeks after the supplementation ended, the Lion’s Mane group’s scores had fallen back toward their baseline levels — a finding the authors described as direct evidence that the mushroom was responsible for the improvements, and that continued daily consumption is required to maintain the neurological benefits.

This washout finding is practically important: it confirms efficacy through reversal upon cessation, but it also means sporadic supplementation will not produce the cognitive outcomes that consistent daily consumption produces.

The Early Alzheimer’s Disease 49-Week Pilot Study

A more recent and longer clinical investigation, published in Frontiers in Aging Neuroscience by Li et al. (2020), studied participants with early Alzheimer’s disease over 49 weeks using erinacine A-enriched Hericium erinaceus mycelium capsules (1.05 grams daily) in a double-blind, placebo-controlled design.

After 49 weeks, the Lion’s Mane group demonstrated higher scores on cognitive and functional assessments including the CASI (Cognitive Abilities Screening Instrument), MMSE (Mini-Mental State Examination), and IADL (Instrumental Activities of Daily Living) scale — meaning participants maintained or improved their ability to perform daily tasks. Blood biomarkers told a parallel story: BDNF levels remained stable in the Lion’s Mane group while declining in the placebo group. Insulin-like growth factor 1 (IGF-1), another neuroprotective marker, also declined significantly in the placebo group but not the Lion’s Mane group. The placebo group showed increasing levels of a biomarker associated with blood-brain barrier breakdown — the Lion’s Mane group did not.

The researchers concluded that erinacine A-enriched Hericium erinaceus appears to delay the progression of cognitive decline in early Alzheimer’s disease — a meaningful outcome given that currently available pharmaceutical interventions offer only modest effects on disease progression.

Acute Cognitive Effects in Healthy Young Adults

A 2023 double-blind, randomized, parallel-groups pilot study published in Nutrients by Docherty et al. examined both the acute (60-minute post-dose) and chronic (28-day) cognitive effects of 1.8 grams daily of Lion’s Mane in 41 healthy adults aged 18–45 years. This is significant because most Lion’s Mane research has focused on cognitively impaired populations — this study tested healthy, young adults.

Following a single dose, participants performed significantly faster on the Stroop task at 60 minutes post-dose (p = 0.005) — a validated measure of processing speed and executive attention. A trend toward reduced subjective stress was observed after 28 days of supplementation (p = 0.051), approaching statistical significance in this small pilot sample. The authors concluded that the findings suggest Lion’s Mane may improve speed of performance and reduce stress in healthy young adults, while appropriately noting that the small sample size requires replication in larger trials.

Gut Health, the Gut-Brain Axis, and Mood Effects

Lion’s Mane contains beta-glucan polysaccharides that function as prebiotic fibers — selectively feeding beneficial gut bacteria. The gut-brain axis connects the enteric nervous system of the digestive tract to the central nervous system through the vagus nerve, immune signaling, and neurotransmitter production. Over 90% of the body’s serotonin is produced in the gut, making gut bacterial health directly relevant to mood, sleep quality, and mental clarity.

A study by Nagano et al. examining the effect of 4-week Lion’s Mane consumption on mood in women with various self-reported complaints found that the Lion’s Mane group reported significantly less anxiety and irritation compared to the placebo group — an effect the researchers attributed partly to the reduction of inflammation and partly to effects on the gut-brain axis rather than only to direct neurotrophin effects. This is consistent with the broader understanding of how gut microbiome composition influences neurological and psychiatric health.

A comprehensive review published in Nutrients (2023) examining neuroprotective effects of Hericium erinaceus confirmed the multi-pathway mechanism: NGF stimulation, BDNF activation, anti-inflammatory effects, beta-glucan prebiotic activity, and direct antioxidant protection of neural tissue all contribute simultaneously to the observed cognitive and mood effects.

The Honest Evidence Gaps — What the Research Does Not Yet Prove

Practical Protocol: How to Use Lion’s Mane Effectively

Quality Selection — What Matters on the Label

• Fruiting body vs. mycelium: The fruiting body contains higher concentrations of hericenones; the mycelium (particularly when erinacine A-enriched) contains higher erinacine concentrations. Premium products specify which they use or include both; the most clinically studied products specify their bioactive compound source
• Beta-glucan content: Quality supplements should specify beta-glucan content of at least 25–30%. If the label does not list beta-glucan percentage, this is a quality signal worth investigating further
• Standardized extract vs. raw powder: Standardized extracts ensure consistent bioactive compound concentrations; raw mushroom powder has variable potency

Dosing and Timing

• Doses used in successful clinical trials: 1 gram to 3 grams daily — the Mori et al. MCI trial used approximately 3g; the Docherty et al. young adult trial used 1.8g; the Li et al. Alzheimer’s study used 1.05g
• Starting point: 1 gram daily is a reasonable starting dose; adjust upward based on individual response over 4–8 weeks
• Timing: Most people take it in the morning due to its focus-supporting effects. Taking it late in the evening may interfere with sleep for some individuals due to increased mental alertness
• Consistency is essential: The 4-week washout reversal in the Mori et al. trial demonstrates that benefits require ongoing daily consumption. Sporadic use does not replicate the study outcomes
• Timeline for effects: Subtle changes are possible within weeks 2–3; more meaningful improvements in memory and focus typically emerge at months 2–3 of consistent daily use

Forms Available

Lion’s Mane is available as powder (added to coffee, tea, or smoothies — mild, slightly earthy flavor), capsules (most convenient for consistent dosing), and liquid extracts (highest bioavailability per unit volume). All forms are appropriate when sourced from quality-standardized products.

Safety Profile and Contraindications

Hericium erinaceus has been consumed as food across Asia for centuries without significant documented adverse effects. Clinical trials have reported it as safe and well-tolerated.

• Mushroom allergy: Anyone with documented mushroom allergy should avoid Lion’s Mane entirely. Allergic reactions, while rare, can include skin rashes, respiratory symptoms, or digestive disturbance
• Blood-thinning medications: Lion’s Mane may have mild antiplatelet properties. Consult your physician if taking warfarin, aspirin therapy, or other anticoagulants
• Pre-surgical: Discontinue at least two weeks before any scheduled surgical procedure due to potential effects on blood clotting time
• Pregnancy and breastfeeding: Avoid supplemental use — not because harm has been demonstrated, but because adequate safety data for these populations does not exist
• Case report note: A published case report described an individual who developed respiratory distress possibly associated with Lion’s Mane consumption. This remains an isolated report, but it underscores that individual reactions can occur and gradual dose escalation is prudent
• Drug interactions: Always inform your physician about any supplements you are taking, as interactions with medications may exist that have not yet been fully characterized

Conclusion: What the Evidence Supports and What It Does Not

The mechanistic case for Lion’s Mane is strong and well-documented: hericenones and erinacines are unique compounds that cross the blood-brain barrier, stimulate NGF and BDNF production, promote neurite outgrowth, and protect against neuroinflammation through multiple independent pathways. This is not contested in the literature.

The human clinical trial evidence shows meaningful positive effects — cognitive improvements in people with mild cognitive impairment (Mori et al., Phytotherapy Research), delayed cognitive decline in early Alzheimer’s disease (Li et al., Frontiers in Aging Neuroscience), and acute processing speed improvements in healthy young adults (Docherty et al., Nutrients). The effects are most consistently documented in populations with existing cognitive vulnerability.

The evidence gaps are real and should not be minimized: trial sizes have been small, a large-scale Australian trial found no benefit in healthy adults, and long-term safety data is limited. The Alzheimer’s Drug Discovery Foundation’s independent assessment describes the cognitive evidence as mixed based on small trials — an honest position that this article reflects.

Lion’s Mane is not a pharmaceutical cure for cognitive decline. It is a food-derived compound with uniquely documented neurotrophin-stimulating mechanisms, a meaningful body of small positive clinical trials in cognitively vulnerable populations, and a strong safety profile established over centuries of consumption. For anyone concerned about long-term brain health — particularly those with a family history of cognitive decline or early subjective memory changes — the evidence supports discussing it with a physician as one component of a comprehensive brain health strategy.

Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Lion’s Mane mushroom supplements are not approved to treat, cure, or prevent any disease including Alzheimer’s disease or any form of cognitive impairment. Always consult a qualified healthcare professional before beginning any supplement regimen, particularly if you have existing health conditions, take prescription medications, or are pregnant or breastfeeding.

References

1. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367–372. https://pubmed.ncbi.nlm.nih.gov/18844328/
2. Lai PL, Naidu M, Sabaratnam V, et al. (2013). Neurotrophic properties of the Lion’s Mane medicinal mushroom, Hericium erinaceus, from Malaysia. International Journal of Medicinal Mushrooms. https://pubmed.ncbi.nlm.nih.gov/24266378/
3. Martínez-Mármol R, et al. (2023). Hericium erinaceus and its erinacine compounds stimulate peripheral nerve regeneration and expression of BDNF via novel p75NTR-independent ERK1/2 signaling. Journal of Neurochemistry. https://onlinelibrary.wiley.com/doi/10.1111/jnc.15767
4. Li IC, Chang HH, Lin CH, et al. (2020). Prevention of early Alzheimer’s disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Frontiers in Aging Neuroscience, 12, 155. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2020.00155/full
5. Docherty S, Doughty FL, Smith EF. (2023). The acute and chronic effects of Lion’s Mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients, 15(22), 4842. https://www.mdpi.com/2072-6643/15/22/4842
6. Ghosh S, et al. (2023). Neuroprotective effects of Hericium erinaceus: comprehensive review. Nutrients. https://pmc.ncbi.nlm.nih.gov/articles/PMC10650066/
7. Alzheimer’s Drug Discovery Foundation. Cognitive Vitality Rating: Lion’s Mane. Independent evidence review. https://www.alzdiscovery.org/cognitive-vitality/ratings/lions-mane